Latest news about Amerise Biosciences
Amerise Biosciences Reports Net Loss in Q1 FY2026 Amid Revenue Decline Jul 24, 2025
Amerise Biosciences Limited, an Ahmedabad-based biosciences company, reported a net loss of Rs. 0.81 lacs for Q1 FY2026, ending June 30, 2025. This marks a significant shift from the previous quarter's profit of Rs. 10.59 lacs. Total income decreased to Rs. 6.37 lacs from Rs. 18.80 lacs in the preceding quarter. The company's revenue came entirely from other operating revenue, with no gross revenue from product sales. Total expenses were Rs. 7.18 lacs, mainly comprising employee benefit expenses and other expenses. The Board of Directors approved these unaudited financial results on July 24, 2025, which were reviewed by the Audit Committee and auditors.